ProfileGDS4272 / AFFX-HUMRGE/M10098_5_at
TitleMethotrexate effect on SPARKS CHARMS juvenile idiopathic arthritis cohort: peripheral blood mononuclear cells
OrganismHomo sapiens


untreated MTX JIA (MTX responder) JIA (MTX non-responder) JIA (MTX responder) JIA (MTX non-responder) A235_L003 A235_L009 A235_L010 A235_L014 A235_L016 A235_L017 A235_L221 A235_L015 A235_L027 A235_L112 A235_287 A235_L003 A235_L009 A235_L010 A235_L014 A235_L016 A235_L017 A235_L221 A235_L015 A235_L027 A235_L112 A235_287 GSM580950 GSM580952 GSM580954 GSM580956 GSM580960 GSM580962 GSM580968 GSM580958 GSM580964 GSM580966 GSM580970 GSM580951 GSM580953 GSM580955 GSM580957 GSM580961 GSM580963 GSM580969 GSM580959 GSM580965 GSM580967 GSM580971 99% 99% 100% 99% 99% 99% 51% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% 99% sort by agent sort by disease state sort by individual Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM580950JIA PBMC Pre treatment A235_L00313.271699
GSM580952JIA PBMC Pre treatment A235_L00913.22199
GSM580954JIA PBMC Pre treatment A235_L01013.4843100
GSM580956JIA PBMC Pre treatment A235_L01412.533799
GSM580960JIA PBMC Pre treatment A235_L01612.973199
GSM580962JIA PBMC Pre treatment A235_L01712.468899
GSM580968JIA PBMC Pre treatment A235_L2215.5077251
GSM580958JIA PBMC Pre treatment A235_L01512.983399
GSM580964JIA PBMC Pre treatment A235_L02712.63899
GSM580966JIA PBMC Pre treatment A235_L11212.734599
GSM580970JIA PBMC Pre treatment A235_28712.683899
GSM580951JIA PBMC Post treatment A235_L003(2)12.895299
GSM580953JIA PBMC Post treatment A235_L009(2)11.995399
GSM580955JIA PBMC Post treatment A235_L010(2)12.365799
GSM580957JIA PBMC Post treatment A235_L014(2)12.53399
GSM580961JIA PBMC Post treatment A235_L016(2)12.377499
GSM580963JIA PBMC Post treatment A235_L017(2)12.692399
GSM580969JIA PBMC Post treatment A235_L221(2)12.802499
GSM580959JIA PBMC Post treatment A235_L015(2)12.682699
GSM580965JIA PBMC Post treatment A235_L027(2)11.846399
GSM580967JIA PBMC Post treatment A235_L112(2)12.70699
GSM580971JIA PBMC Post treatment A235_287(2)12.622699